PURPOSE: Clinical trials have demonstrated the benefits of exercise for cancer survivors. This investigation determined the effectiveness and safety of a disseminated community-based exercise program for cancer survivors who had completed treatment. METHODS: Personal trainers from regional YMCAs received training in cancer rehabilitation and supervised twice-a-week, 12-week group exercise sessions for survivors. At baseline and post-program, validated measures assessed patient-reported outcomes (PRO) and physiologic measurements. RESULTS: Data were collected from 221 survivors from 13 YMCA sites and 36 separate classes. All participants had data available at one time point, while matched baseline and post-program PRO and physiologic data were available for 85% (N = 187). Participants with matched data were largely female (82%), with mean age of 58 (range, 28-91 years). Time since diagnosis ranged from 1 to 48 (mean, 5.6 years), and mean time since last treatment was 3.0 (range, 1-33 years). Physiological improvements were significant in systolic (P < 0.001) and diastolic (P = 0.035) blood pressure, upper and lower body strength, the 6-min walk test (P = 0.004), and flexibility (P < 0.001). Participants reported improvements in overall health-related quality of life (P < 0.001), social support (P = 0.019), body pain (P = 0.016), fatigue (P < 0.001), insomnia (P < 0.001), and overall musculoskeletal symptoms (P = <0.001). Few injuries or lymphedema events occurred during classes. CONCLUSIONS: Community-based exercise groups for cancer survivors of mixed diagnoses and ages, who have completed active treatment, have physiologic and psychosocial benefits, and are safe. IMPLICATIONS FOR CANCER SURVIVORS: Survivors may expect significant benefit from participating in a community-based exercise program tailored to meet their individual needs as a survivor.
PURPOSE: Clinical trials have demonstrated the benefits of exercise for cancer survivors. This investigation determined the effectiveness and safety of a disseminated community-based exercise program for cancer survivors who had completed treatment. METHODS: Personal trainers from regional YMCAs received training in cancer rehabilitation and supervised twice-a-week, 12-week group exercise sessions for survivors. At baseline and post-program, validated measures assessed patient-reported outcomes (PRO) and physiologic measurements. RESULTS: Data were collected from 221 survivors from 13 YMCA sites and 36 separate classes. All participants had data available at one time point, while matched baseline and post-program PRO and physiologic data were available for 85% (N = 187). Participants with matched data were largely female (82%), with mean age of 58 (range, 28-91 years). Time since diagnosis ranged from 1 to 48 (mean, 5.6 years), and mean time since last treatment was 3.0 (range, 1-33 years). Physiological improvements were significant in systolic (P < 0.001) and diastolic (P = 0.035) blood pressure, upper and lower body strength, the 6-min walk test (P = 0.004), and flexibility (P < 0.001). Participants reported improvements in overall health-related quality of life (P < 0.001), social support (P = 0.019), body pain (P = 0.016), fatigue (P < 0.001), insomnia (P < 0.001), and overall musculoskeletal symptoms (P = <0.001). Few injuries or lymphedema events occurred during classes. CONCLUSIONS: Community-based exercise groups for cancer survivors of mixed diagnoses and ages, who have completed active treatment, have physiologic and psychosocial benefits, and are safe. IMPLICATIONS FOR CANCER SURVIVORS: Survivors may expect significant benefit from participating in a community-based exercise program tailored to meet their individual needs as a survivor.
Authors: Sherry L Pagoto; Kristin L Schneider; Jessica L Oleski; Juliana M Luciani; Jamie S Bodenlos; Matt C Whited Journal: Obesity (Silver Spring) Date: 2011-06-02 Impact factor: 5.002
Authors: Shana Harrington; Darin Padua; Claudio Battaglini; Lori A Michener; Carol Giuliani; Joseph Myers; Diane Groff Journal: J Cancer Surviv Date: 2011-01-12 Impact factor: 4.442
Authors: Justin C Brown; Tania B Huedo-Medina; Linda S Pescatello; Shannon M Pescatello; Rebecca A Ferrer; Blair T Johnson Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-11-04 Impact factor: 4.254
Authors: Simone Oerlemans; Floortje Mols; Marten R Nijziel; Marnix Lybeert; Lonneke V van de Poll-Franse Journal: Ann Hematol Date: 2011-06-14 Impact factor: 3.673
Authors: Kasey J Leger; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Wendy M Leisenring; Paul J Martin; Jason A Mendoza; Kerryn W Reding; Karen L Syrjala; Stephanie J Lee; Eric J Chow Journal: Cancer Date: 2018-01-09 Impact factor: 6.860
Authors: D Santa Mina; D Au; J Brunet; J Jones; G Tomlinson; N Taback; D Field; A Berlingeri; H Bradley; D Howell Journal: Curr Oncol Date: 2017-10-25 Impact factor: 3.677
Authors: Raquel Peña; Oscar E Suman; Marta Rosenberg; Clark R Andersen; David N Herndon; Walter J Meyer Journal: Arch Phys Med Rehabil Date: 2017-11-26 Impact factor: 3.966
Authors: Amy A Kirkham; Sarah E Neil-Sztramko; Joanne Morgan; Sara Hodson; Sarah Weller; Tasha McRae; Kristin L Campbell Journal: Support Care Cancer Date: 2015-01-25 Impact factor: 3.603
Authors: Maria C Swartz; Zakkoyya H Lewis; Elizabeth J Lyons; Kristofer Jennings; Addie Middleton; Rachel R Deer; Demi Arnold; Kaitlin Dresser; Kenneth J Ottenbacher; James S Goodwin Journal: Arch Phys Med Rehabil Date: 2017-04-17 Impact factor: 3.966
Authors: Ryan J Marker; Emily Cox-Martin; Catherine M Jankowski; W Thomas Purcell; John C Peters Journal: Support Care Cancer Date: 2017-12-21 Impact factor: 3.603
Authors: Eric J Chow; K Scott Baker; Stephanie J Lee; Mary E D Flowers; Kara L Cushing-Haugen; Yoshihiro Inamoto; Nandita Khera; Wendy M Leisenring; Karen L Syrjala; Paul J Martin Journal: J Clin Oncol Date: 2013-12-02 Impact factor: 44.544